Patents Assigned to Geneheal Biotechnology Co., Ltd.
  • Patent number: 11766412
    Abstract: Provided are compounds reducing SAICAR accumulation, and applications. On the basis of existing protein structure data and small molecule structure data, calculations and analysis are performed using software to screen and obtain compounds capable of effectively interfering with PAICS activity, reducing SAICAR synthesis, and ultimately reducing SAICAR accumulation, in order to achieve the goal of treating or improving ADSL deficiency. A better effect in the treatment or improvement of ADSL deficiency is expected from the joint use of at least two of the described compounds.
    Type: Grant
    Filed: September 26, 2017
    Date of Patent: September 26, 2023
    Assignee: Geneheal Biotechnology Co., Ltd.
    Inventors: Wuguang Pan, Wei Zhu
  • Patent number: 11684593
    Abstract: Applications of spermine or its pharmaceutically acceptable derivative in preparation of an SAICAR synthetase activity interfering agent or inhibitor. Applications of spermine or its pharmaceutically acceptable derivative in preparation of antitumor drug.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: June 27, 2023
    Assignee: Geneheal Biotechnology Co., Ltd.
    Inventors: Wei Zhu, Wuguang Pan
  • Patent number: 11517541
    Abstract: Disclosed are applications of spermidine or its pharmaceutically acceptable derivatives. The inventors performed calculation and analysis using software based on existing data relating to protein and small-molecule structures, and screened out compounds which can effectively interfere with the activity of PAWS and thus reduce SAICAR synthesis, thereby achieving the goal of treating or improving tumors. It is expected to produce better effect in the treatment or improvement of tumors.
    Type: Grant
    Filed: March 12, 2018
    Date of Patent: December 6, 2022
    Assignee: Geneheal Biotechnology Co., Ltd.
    Inventors: Wei Zhu, Wuguang Pan
  • Patent number: 10709676
    Abstract: Provided are applications of spermine and derivatives thereof. On the basis of existing protein structure data and small molecule structure data, calculations and analysis are performed using software to screen and obtain compounds capable of effectively interfering with PAICS activity, reducing SAICAR synthesis, and ultimately reducing SAICAR accumulation, in order to achieve the goal of treating or reducing ADSL deficiency. A better effect in the treatment or improvement of ADSL deficiency is expected from the joint use of at least two of the described compounds.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: July 14, 2020
    Assignee: Geneheal Biotechnology Co., Ltd.
    Inventors: Wuguang Pan, Wei Zhu